- Home
- RCEL vs BCV Comparison
RCEL vs BCV Comparison
Compare RCEL & BCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCEL
- BCV
- Stock Information
- Founded
- RCEL N/A
- BCV 1971
- Country
- RCEL United States
- BCV United States
- Employees
- RCEL N/A
- BCV N/A
- Industry
- RCEL Medical/Dental Instruments
- BCV Finance/Investors Services
- Sector
- RCEL Health Care
- BCV Finance
- Exchange
- RCEL Nasdaq
- BCV Nasdaq
- Market Cap
- RCEL 140.5M
- BCV 130.9M
- IPO Year
- RCEL N/A
- BCV N/A
- Fundamental
- Price
- RCEL $5.54
- BCV $22.33
- Analyst Decision
- RCEL Strong Buy
- BCV
- Analyst Count
- RCEL 4
- BCV 0
- Target Price
- RCEL $13.75
- BCV N/A
- AVG Volume (30 Days)
- RCEL 1.3M
- BCV 26.3K
- Earning Date
- RCEL 11-06-2025
- BCV 01-01-0001
- Dividend Yield
- RCEL N/A
- BCV 8.13%
- EPS Growth
- RCEL N/A
- BCV N/A
- EPS
- RCEL N/A
- BCV N/A
- Revenue
- RCEL $74,884,000.00
- BCV N/A
- Revenue This Year
- RCEL $22.92
- BCV N/A
- Revenue Next Year
- RCEL $37.07
- BCV N/A
- P/E Ratio
- RCEL N/A
- BCV N/A
- Revenue Growth
- RCEL 38.32
- BCV N/A
- 52 Week Low
- RCEL $3.60
- BCV $14.09
- 52 Week High
- RCEL $14.16
- BCV $18.11
- Technical
- Relative Strength Index (RSI)
- RCEL 54.84
- BCV 70.86
- Support Level
- RCEL $5.03
- BCV $21.54
- Resistance Level
- RCEL $5.61
- BCV $22.05
- Average True Range (ATR)
- RCEL 0.39
- BCV 0.35
- MACD
- RCEL 0.00
- BCV -0.01
- Stochastic Oscillator
- RCEL 34.69
- BCV 93.70
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.
About BCV Bancroft Fund Ltd.
Bancroft Fund Ltd is a diversified closed-end management company. It operates as a closed-ended equity mutual fund. The funds' main objective is to provide income and potential for capital appreciation. With the intent to achieve its objective, the company invests in convertible and equity securities. It invests across different industries such as Computer Software and Services, Energy and Utilities, Health Care among others.